Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| Yesterday 4:30 PM View:  | Ars Pharmaceuticals, Inc. (SPRY) | 19-Nov-24 | Private Sale (Planned) Duplicate | 100,000 | $13.95 | $1,394,960.00 | (< 1%) 11.67M to 11.57M | |
| 14-Nov-24 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 12-Nov-24 | Private Sale (Planned) | 100,000 | $16.85 | $1,684,640.00 | (< 1%) 11.77M to 11.67M | |
| 10-Oct-24 4:27 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Oct-24 | Private Sale (Planned) | 100,000 | $13.83 | $1,382,770.00 | (< 1%) 11.97M to 11.87M | |
| 19-Sep-24 4:26 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 17-Sep-24 | Private Sale (Planned) | 100,000 | $12.93 | $1,293,210.00 | (< 1%) 12.07M to 11.97M | |
| 12-Sep-24 4:24 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 10-Sep-24 | Private Sale (Planned) Duplicate | 100,000 | $11.50 | $1,149,780.00 | (< 1%) 12.17M to 12.07M | |
| 21-Aug-24 6:47 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Private Sale (Planned) | 100,000 | $15.03 | $1,502,590.00 | (< 1%) 12.27M to 12.17M | |
| 15-Aug-24 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 13-Aug-24 | Private Sale (Planned) Duplicate | 100,000 | $12.48 | $1,247,560.00 | (< 1%) 12.37M to 12.27M | |
| 18-Jul-24 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 16-Jul-24 | Private Sale (Planned) | 100,000 | $11.40 | $1,140,300.00 | (< 1%) 12.47M to 12.37M | |
| 11-Jul-24 5:03 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 09-Jul-24 | Private Sale (Planned) Duplicate | 100,000 | $9.62 | $961,725.00 | (< 1%) 12.57M to 12.47M | |
| 13-Jun-24 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 12-Jun-24 | Sale (Planned) Duplicate | 95,862 | $9.15 | $876,663.00 | (< 1%) 12.66M to 12.57M | |
| 13-Jun-24 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 11-Jun-24 | Private Sale (Planned) Duplicate | 4,138 | $9.00 | $37,254.00 | (< 1%) 12.67M to 12.66M | |
| 16-May-24 7:51 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 16-May-24 | Sale (Planned) | 89,096 | $9.06 | $807,023.00 | (< 1%) 14.4M to 14.31M | |
| 16-May-24 7:51 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 15-May-24 | Sale (Planned) | 5,147 | $9.05 | $46,564.70 | (< 1%) 14.4M to 14.4M | |
| 16-May-24 7:51 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 14-May-24 | Private Sale (Planned) | 5,757 | $9.01 | $51,853.90 | (< 1%) 14.41M to 14.4M | |
| 09-May-24 6:57 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 07-May-24 | Private Sale (Planned) | 100,000 | $9.34 | $934,365.00 | (< 1%) 12.87M to 12.77M | |
| 24-Apr-24 6:17 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 23-Apr-24 | Option Exercise Duplicate | 130,993 | $1.06 | $138,990.00 | 1% 12.73M to 12.87M | |
| 22-Apr-24 7:22 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 19-Apr-24 | Option Exercise | 188,491 | $1.06 | $199,999.00 | 2% 12.55M to 12.73M | |
| 17-Apr-24 6:40 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 16-Apr-24 | Private Sale (Planned) | 100,000 | $9.28 | $928,005.00 | (< 1%) 12.65M to 12.55M | |
| 10-Apr-24 5:36 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 09-Apr-24 | Private Sale (Planned) | 100,000 | $9.28 | $927,735.00 | (< 1%) 12.75M to 12.65M | |
| 26-Mar-24 6:48 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 25-Mar-24 | Sale (Planned) Duplicate | 95,267 | $9.12 | $869,188.00 | (< 1%) 12.84M to 12.75M | |
| 26-Mar-24 6:48 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 22-Mar-24 | Private Sale (Planned) Duplicate | 2,343 | $9.02 | $21,134.80 | (< 1%) 12.84M to 12.84M | |
| 21-Mar-24 9:51 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 21-Mar-24 | Sale (Planned) Duplicate | 472 | $9.00 | $4,248.00 | (< 1%) 12.84M to 12.84M | |
| 21-Mar-24 9:51 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 19-Mar-24 | Private Sale (Planned) Duplicate | 1,918 | $9.03 | $17,324.10 | (< 1%) 12.85M to 12.84M | |
| 15-Mar-24 7:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 15-Mar-24 | Sale (Planned) Duplicate | 96,756 | $9.14 | $884,485.00 | (< 1%) 12.94M to 12.85M | |
| 15-Mar-24 7:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 14-Mar-24 | Sale (Planned) Duplicate | 444 | $9.00 | $3,996.00 | (< 1%) 12.94M to 12.94M | |
| 15-Mar-24 7:55 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 13-Mar-24 | Private Sale (Planned) Duplicate | 2,800 | $9.00 | $25,200.00 | (< 1%) 12.95M to 12.94M | |
| 01-Mar-24 8:17 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 29-Feb-24 | Private Sale (Planned) | 3,782 | $9.02 | $34,100.60 | (< 1%) 12.95M to 12.95M | |
| 28-Feb-24 9:04 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 28-Feb-24 | Sale (Planned) | 98,778 | $9.02 | $891,061.00 | (< 1%) 13.05M to 12.95M | |
| 28-Feb-24 9:04 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 26-Feb-24 | Private Sale (Planned) | 700 | $9.01 | $6,307.00 | (< 1%) 13.05M to 13.05M | |
| 04-Jan-24 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 17-May-23 | Gift Duplicate | 2,100,000 | -- | -- | 16% 13.05M to 15.15M | |
| 04-Jan-24 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 17-May-23 | Gift | 1,050,000 | -- | -- | (7%) 15.15M to 14.1M | |
| 04-Jan-24 4:53 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 17-May-23 | Gift Duplicate | 1,050,000 | -- | -- | (7%) 14.1M to 13.05M | |
| 10-Nov-22 6:00 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Nov-22 | Grant | 5,176,820 | -- | -- | 100% 0 to 5.18M | |
| 10-Nov-22 6:00 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Nov-22 | Grant | 7,872,550 | -- | -- | 152% 5.18M to 13.05M |